The estimated Net Worth of Billie R. Haggard is at least $21.6 Million dollars as of 29 July 2015. Billie Haggard owns over 46,644 units of Cencora stock worth over $21,408,619 and over the last 14 years Billie sold COR stock worth over $163,866.
Billie has made over 11 trades of the Cencora stock since 2010, according to the Form 4 filled with the SEC. Most recently Billie exercised 46,644 units of COR stock worth $894,632 on 29 July 2015.
The largest trade Billie's ever made was exercising 46,644 units of Cencora stock on 29 July 2015 worth over $894,632. On average, Billie trades about 2,990 units every 90 days since 2010. As of 29 July 2015 Billie still owns at least 90,630 units of Cencora stock.
You can see the complete history of Billie Haggard stock trades at the bottom of the page.
Billie's mailing address filed with the SEC is 1050 17TH STREET, SUITE 800, , DENVER, CO, 80265.
Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv..., and Group Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Cencora executives and other stock owners filed with the SEC include: